Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Failure
63%
Carcinogenicity
9%
Ferric Carboxymaltose
90%
Ferritin
15%
Gelatinase B
6%
Heart Failure
100%
Heart Muscle Fibrosis
30%
Iron Deficiency
84%
Prognosis
33%
Randomized Controlled Trial
30%
Tissue Inhibitor of Metalloproteinase 4
9%
Medicine and Dentistry
Age
6%
Heart Arrest
60%
Hospital
42%
Inpatient
30%
Male
6%
Nervous System Physiology
6%
Observational Study
6%
Overall Survival
6%
Patient
36%
Physician
6%
Resuscitation
60%
Smoking
5%
Biochemistry, Genetics and Molecular Biology
Atrial Fibrillation
30%
Classification
30%
Galectin-3
6%
Growth Differentiation Factor
9%
Metalloprotease Inhibitor
12%
MMP9
6%
Protein
18%
Survival
5%
Volume
6%
